B. Riley lowered the firm’s price target on Aspen Aerogels (ASPN) to $4 from $10 and keeps a Buy rating on the shares. The company is taking appropriate actions to weather a tough macro backdrop as the EV market resets, with a focus on cash, cost reduction, and driving long-term value creation, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN:
- Aspen Aerogels price target lowered to $3 from $6 at Roth Capital
- Aspen Aerogels Charts Cost-Cut Path Amid EV Slowdown
- Aspen Aerogels Launches Strategic Review Amid 2025 Downturn
- Aspen Aerogels initiates strategic review to evaluate opportunities
- Aspen Aerogels sees Q1 EPS (28c)-(24c), consensus (13c)